Lindsey Demeritt, MSEd, CRA, CPRA
o. 407.271.4250 | m. 407.919.9556
Your institution can charge their applicable negotiated rate. The PTE may have given you an overall limit that you have to work with. But they need to understand that the $499,000 DC cap does not include subcontractor F&A.
_______________
James Cappellucci
Senior Grants & Contracts Administrator, Pre-Award
Authorized Business Official
Mass General Brigham
399 Revolution Drive, Suite 735 |Somerville, MA 02145| 857.282.1724
In-office remotely 8:30 AM ~ 5:00 PM
For subcontracts and foundation award transmittal and status inquiries, please contact
xxxxxx@partners.org | xxxxxx@partners.org | xxxxxx@partners.org
From: xxxxxx@lists.healthresearch.org <xxxxxx@lists.healthresearch.org> On Behalf Of Escher, Jennifer
Sent: Tuesday, January 09, 2024 3:14 PM
To: xxxxxx@lists.healthresearch.org
Subject: [RESADM-L] How to Calculate Direct Cost Base with Subs
External Email - Use Caution
Hello hive mind!
In my current position, we only do subawards PTE on NIH awards, mainly R01. Something weird happened today and I would like the collectives opinion’s on which way is correct of what you do, specific to NIH only.
As mentioned we only really do subs and every sub I have done in my career here and elsewhere, we have been given a budget, let’s say $100,000 per year for a total of $500,000 over the 5 year period for direct costs and then indirect are on top of that. Today, a university that does a lot of work in NIH, said our budget was $100,000 per year inclusive of indirect costs. We had just done another grant with a different PI and Grant Admin from this same university and this was not the case. The PI spoke up in the email exchange and said that all subawards indirect costs come from their (Prime) indirect costs and thus that is why he had to give us the way he did.
I have never done it this way or ever heard of it way. I guess from all of you who has way more expereince than I, is this true? Does my indirect as a subwab get awarded from your indirect as a PTE?
This is the specific NOFA in case you are wondering: PAR-21-166: Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed) (nih.gov)
To be fair, I have no concreate policy from NIH on this, it truly has been just how we have always done it. But I don’t want to be that person if it not the case, I would love to know differently. I did find these items below, but not sure they 100% solidify my point.
2.3.7 Policies Affecting Applications (nih.gov)
2.3.7.1 For FOAs that include a direct cost limit, NIH policy excludes consortium/contractual F&A when determining if an applicant is in compliance with the direct cost limitation
Develop Your Budget | grants.nih.gov
Section: What is the difference between allowable direct costs and allowable facilities & administrative (F&A) costs?
Jennifer Escher, M.Ed.
Grants Administrator
Siemens Medical Solutions USA, Inc.
40 Liberty Boulevard
Malvern, PA 19355, USA
+1 470.927.2885
xxxxxx@siemens-healthineers.com
- = - = - = - = - = - = -
This email was sent to xxxxxx@mgb.org via the Research Administrator's mailing list.
To unsubscribe from RESADM-L, go to https://lists.healthresearch.org and go into the Account Settings area.
List archives are available at: https://lists.healthresearch.org/resadm-l
To change your settings (such as Digest Mode or to temporarily suspend list emails): https://lists.healthresearch.orgThe information in this e-mail is intended only for the person to whom it is addressed. If you believe this e-mail was sent to you in error and the e-mail contains patient information, please contact the Mass General Brigham Compliance HelpLine at https://www.massgeneralbrigham.org/complianceline .
Please note that this e-mail is not secure (encrypted). If you do not wish to continue communication over unencrypted e-mail, please notify the sender of this message immediately. Continuing to send or respond to e-mail after receiving this message means you understand and accept this risk and wish to continue to communicate over unencrypted e-mail.
- = - = - = - = - = - = -
This email was sent to xxxxxx@GMAIL.COM via the Research Administrator's mailing list.
To unsubscribe from RESADM-L, go to https://lists.healthresearch.org and go into the Account Settings area.
List archives are available at: https://lists.healthresearch.org/resadm-l
To change your settings (such as Digest Mode or to temporarily suspend list emails): https://lists.healthresearch.org